Article Sidebar

Submitted
December 21, 2025
Accepted
December 21, 2025
Published
December 21, 2025
Download
PDF
Statistic
Read Counter : 198 Download : 77

Main Article Content

Abstract

Background: Giardia lamblia is the cause of giardiasis, one of the most prevalent
parasitic illnesses in the world that affects millions of people annually. Although
the majority of infections are most likely asymptomatic, some are linked to
intestinal irritation and subacute or chronic diarrhea, which can lead to
malabsorption and nutritional deficiencies, particularly in children.Aim of study
:is to Assessment of interleukin 37 and some immune parameters in patients with
giardiasis .Patients and methods:The stool samples were collected and labeled
with the patient's information in sterile plastic containers and checked via the
naked eye for colour, consistency, after that, they were analyzed using light
microscopy to check for the presence of Giardia trophozoite and cyst
stage.(45)blood samples were taken from suspected G. lamblia patients, and (45)
blood samples from healthy individuals as a control group. Blood samples were
captured to enable to establish the white blood cell (WBC) count. Results: The
outcomes of the research demonstrated that both male and female patients
infected with G. lamblia had significantly lower levels of IL-37 (p >0.05) in their
72.36 ±10.87 concentrations than in the control group (86.51 ±11.83). WBC
levels It reveals a substantial rise in the number of infected patients (8.94 ± 4.36)
in contrast to 7.44 ± 2.4 of the control collective. (P<0.05) . Conclusion : the
spread of the disease depends on the environmental conditions as well as on
factors specific to the host and the strength of occurrence affected by these
conditions.

Keywords

Giardia lamblia Giardiasis Diarrhea interleukin 37

Article Details

License

Copyright (c) 2025 Milad abdulkathem lahmod, Murtada Hafedh Hussein

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

  1. ADAM, Rodney D. Giardia duodenalis: biology and pathogenesis. Clinical microbiology reviews,2021,34.4:e00024
  2. DOI:10.1128/cmr.00024-19.
  3. ABDULHALEEM, Noor, et al. An overview of the prevalence and distribution of gastrointestinal parasitic infections in
  4. post-war Iraq. Tropical Journal of Pharmaceutical Research, 2017, 16.6: 1443-1451. DOI:10.4314/tjpr.v16i6.32.
  5. HUSSEIN, Murtada Hafedh, et al. Estimation of TNF-α and some immunological parameters in patient with systemic
  6. lupus erythematosus. University of Thi-Qar Journal of Science, 2024, 11.2: 30-33. DOI:10.32792/utq/utjsci/v11i2.1197.
  7. AL-MUSAWY, Fatima Assad Baker; HUSSEIN, Murtada Hafedh. Evaluation of Interleukin-1β, GOT, and GPT in
  8. Patients with Giardiasis in Thi-Qar Province. University of Thi-Qar Journal of Science, 2022, 9.1: 68-71.(No DOI
  9. avialable).
  10. RYAN, Una; PAPARINI, Andrea; OSKAM, Charlotte. New technologies for detection of enteric parasites. Trends in
  11. parasitology, 2017, 33.7: 532-546.DOI:10.1016/j.pt.2017.02.005.
  12. BEKELE, Damtew; RETA, Toli. Prevalence and distribution of Giardia lamblia infection among patients of children
  13. aged 5-11years treated in Sheno town health centers, North Shoa Oromia region, Ethiopia. Clinical Research and
  14. Studies, 2023, 2.1: 2835-2882.DOI:10.31579/2835-2882/008.
  15. BURET, Andre G., et al. Giardia duodenalis: new research developments in pathophysiology, pathogenesis, and virulence
  16. factors. Current tropical medicine reports, 2015, 2: 110-118. DOI:10.1007/s40475-015-0043-4
  17. CAVALLI, Giulio, et al. The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity. Cell Reports, 2021,
  18. 1. DOI:10.1016/j.celrep.2021.108951.
  19. CONTI, Pio, et al. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition. Tissue and Cell,
  20. , 49.3: 393-400.DOI:10.1016/j.tice.2017.03.005
  21. CONTI, Pio, et al. Impact of mast cells in mucosal immunity of intestinal inflammation: inhibitory effect of IL-37. European
  22. Journal of Pharmacology, 2018, 818: 294-299.DOI:10.1016/j.ejphar.2017.10.038.
  23. DUNN, Noel; JUERGENS, Andrew L. Giardiasis. In: StatPearls [Internet]. StatPearls Publishing, 2024.(No DOI available)
  24. HILAL, Suaad; HAMIM, Saad S. Seroprvalence of Transforming Growth Factor-β1 and some hormones on Male Infertility in
  25. Nasiriya City, Iraq. University of Thi-Qar Journal of Science, 2023, 10.1: 150-153.(No DOI available).
  26. FEKETE, Elena, et al. Giardia spp. and the gut microbiota: dangerous liaisons. Frontiers in microbiology, 2021, 11: 618106.
  27. DOI:10.3389/fmicb.2020.618106.
  28. FINK, Marc Y.; SINGER, Steven M. The intersection of immune responses, microbiota, and pathogenesis in giardiasis. Trends
  29. in parasitology, 2017, 33.11: 901-913.DOI:10.1016/j.pt.2017.07.007.
  30. GADELHA, Ana Paula Rocha; BENCHIMOL, Marlene; DE SOUZA, Wanderley. Nanoarchitecture of the ventral disc of
  31. Giardia intestinalis as revealed by high-resolution scanning electron microscopy and helium ion microscopy. Histochemistry
  32. and Cell Biology, 2022, 157.2: 251-265.DOI:10.1007/s00418-021-02045-4.
  33. GRITSENKO, Valentina, et al. Russian social work student fear, psycho-emotional well-being, substance use, and
  34. resilience. Journal of Loss and Trauma, 2022, 27.4: 389-392. DOI:10.1080/15325.2021.1878093.
  35. HUSSEIN, Murtada Hafedh; ABBAS, Shatha Khudhaier; MAHDI, Ali Abdul Hussian. Isolation and diagnosis of Entamoeba
  36. histolytica in patients with diarrhea in Baghdad city by more diagnostic method and cultivation of parasite at modified culture
  37. media. Biochemical & Cellular Archives, 2018, 18.1. (No DOI available).
  38. HUSSEIN, Murtada Hafedh; KHALAF, Moslim Mohsin. Association of interleukin-6 and interleukin-1-β levels in patients with
  39. toxoplasmosis. Annals of Parasitology, 2022, 68.2. DOI:10.17420/ap6802.437.
  40. HUSSEIN, M. H., et al. Immunological and Biochemical Glimpses of Giardiasis in Thalassemic Patients. Iranian Journal of
  41. War and Public Health, 2023, 15.4: 429-433.DOI:10.17420/ap7201.423.
  42. JARAMILLO-RANGEL, Gilberto, et al. Nestin-expressing cells in the lung: the bad and the good parts. Cells, 2021, 10.12:
  43. DOI:10.3390/cells10123413.
  44. JASSIM, Marwa Mohammed Ali; NAJI, Shaymaa A.; MAHMOOD, Majid Mohammed. BRCA1, BCL2, and the RB Tumor
  45. Suppressor have abnormal expressions in lung cancer. Research Journal of Pharmacy and Technology, 2022, 15.9: 4083
  46. DOI:10.52711/0974-360x.00685.
  47. LEUNG, Alexander KC, et al. Giardiasis: an overview. Recent patents on inflammation & allergy drug discovery, 2019, 13.2:
  48. -143.DOI:10.2174/1872213x13666190618124901.
  49. LI, Xinrui, et al. Recent advances in progresses and prospects of IL-37 in central nervous system diseases. Brain Sciences,
  50. , 12.6: 723.DOI:10.3390/brainsci12060723.
  51. MAHMOUDI, M. R., et al. Report of Giardia assemblages and giardiasis in residents of Guilan province—Iran. Parasitology
  52. Research, 2020, 119: 1083-1091. DOI: 10.1007/s00436-019-06595-1.
  53. PARIDA, Prasanta Kumar, et al. A prospective study on incidence, risk factors, and validation of a risk score for post-infection
  54. irritable bowel syndrome in coastal eastern India. Indian Journal of Gastroenterology, 2019, 38: 134-142. DOI: 10.1007/s12664-019
  55. -w.
  56. RAFIEI, Vahid, et al. An improved calibration technique to address high dimensionality and non-linearity in integrated
  57. groundwater
  58. and surface water models. Environmental modelling & software, 2022, 149: 105312.
  59. DOI:10.1016/j.envsoft.2022.105312.
  60. ROSHIDI, Norhamizah, et al. Current state of infection and prevalence of giardiasis in Malaysia: a review of 20 years of
  61. research. PeerJ, 2021, 9: e12483.DOI:10.7717/peerj.12483.
  62. GRIGG, Michael E. Intestinal immune responses. Rising Stars in Parasite Immunology 2021, 2022, 177.
  63. DOI:10.3389/978-2-83250-877-0.
  64. SISU, Abubakari, et al. Intestinal parasite infections in diabetes mellitus patients; A cross-sectional study of the
  65. Bolgatanga municipality, Ghana. Scientific African, 2021, 11: e00680.DOI:10.1016/j.sciaf.2020.e00680.
  66. KAZEM, S. H.; HUSSEIN, M. H. Immunological Role of IL-17A and Biochemical Factors in Patients with Renal Failure
  67. Induced by Systemic Lupus Erythematosus. Iranian Journal of War and Public Health, 2024, 16.1: 61
  68. DOI:10.1136/lupus-2017-000215.
  69. SQUIRE, Sylvia Afriyie; RYAN, Una. Cryptosporidium and Giardia in Africa: current and future challenges. Parasites &
  70. vectors, 2017, 10: 1-32. DOI: 10.1186/s13071-017-2111-y.
  71. THEOHARIDES, Theoharis C.; TSILIONI, Irene; CONTI, Pio. Mast cells may regulate the anti-inflammatory activity of IL
  72. International Journal of Molecular Sciences, 2019, 20.15: 3701. DOI: 10.3390/ijms20153701.
  73. WANG, Xiaoying, et al. Role of interleukin-37 in inflammatory and autoimmune diseases. Iranian journal of Immunology, 2018,
  74. 3: 165-174. DOI: 10.22034/IJI.2018.39386.
  75. WOSCHKE, Andreas, et al. Suitability of current typing procedures to identify epidemiologically linked human Giardia
  76. duodenalis isolates. PLoS Neglected Tropical Diseases, 2021, 15.3: e0009277. DOI: 10.1371/journal.pntd.0009277.
  77. YILMAZ, H.; ABDULLAH, A. Prevalence of intestinal parasites (Entamoeba species and Giardia lamblia) in Duhok and
  78. Erbil cities. Northern Iraq. J Microbiol Exp, 2017, 4.6: 119-122.DOI:10.15406/jmen.2017.04.00132.
  79. ZAJACZKOWSKI, Patricia, et al. The controversies surrounding Giardia intestinalis assemblages A and B. Current Research in
  80. Parasitology & Vector-Borne Diseases, 2021, 1: 100055. DOI: 10.1016/j.crpvbd.2021.100055.
  81. ZENG, Huiqiong; ZHOU, Kaixia; YE, Zhizhong. Biology of interleukin-37 and its role in autoimmune diseases. Experimental
  82. and Therapeutic Medicine, 2022, 24.2: 495. DOI: 10.3892/etm.2022.11422

Similar Articles

You may also start an advanced similarity search for this article.